News & Articles
Selected Filters:
Thermo Fisher Scientific develops COVID-19 antibody assay targeting transplant community
This powerful new solution aims to provide more accurate COVID-19 antibody detection
Role of serology in the next phase of COVID-19 investigation and response
Join us on Tuesday, August 11, to learn about a novel serological platform used for COVID-19 testing
Important considerations for choosing a SARS-CoV-2 assay
Join us on Monday, August 17, to discover solutions for your laboratory's SARS-CoV-2 testing
Are two antibodies better than one?
Vanderbilt researchers use high-throughput data collection, analysis, and visualization to help understand synergy in therapeutic antibody cocktails
Rapid and functional evaluation of virus-neutralizing antibodies using multi-parametric live cell analysis
Join us on Wednesday, August 26, to learn about an alternative assay that aims to identify virus-neutralizing antibodies in as little as five hours
FDA approves GSK’s BLENREP for the treatment of patients with relapsed or refractory multiple myeloma
BLENREP is the fifth major medicine approval for GSK in 2020
Could you be the next winner in our weekly ‘Every Opinion Counts’ giveaway?
Just leave a quick lab product review today for your chance to scoop one of our weekly $100 prizes
Siemens Healthineers obtains first FDA EUA for semi-quantitative antibody test
With this numerical result expressed as index value, clinicians will be better equipped to evaluate the duration and level of an individual’s immune response
9 top resources for your COVID-19 & infectious disease research
Exclusive interviews, new methods, free downloads, and much more to help you advance your work
UK COVID-19 rapid antibody tests approved for professional use
Rapid antibody test receives CE mark for use by healthcare professionals
How to improve accuracy and consistency in cell culture research with the right filtration system
Nate Starbard, Thermo Fisher Scientific, discusses how to overcome common filtration challenges in the lab
From B cells to yeast – diverse approaches to rapid discovery of COVID-19 therapeutic antibodies
Join us on Thursday, August 6, to learn about the approaches used by two scientific groups who have accelerated antibody discovery with these pipeline technologies
Hitachi to support researches in infectious diseases through the Hitachi Global Foundation
This support will contribute to the measures against COVID-19, following provision of medical equipment and supplies, employee donations, and loans through NPO
Arctoris contributes its capabilities and expertise to the fight against COVID-19
Establishing a broad range of remotely accessible COVID-19 assays including biochemical profiling for COVID-19 drug targets
Luminex receives FDA emergency use authorization for COVID-19 antibody test
xMAP SARS-CoV-2 Multi-Antigen IgG Assay is enabled by xMAP Technology, the gold standard for multiplexing serologic testing
Takeda partners with Twist Bioscience to expand biologics discovery capabilities
The partnership aims to bring access to Twist's proprietary phage display libraries for the discovery of antibodies in Takeda's biologics pipeline
EKF introduces novel molecular transport media for dual COVID-19 and influenza sampling
Patented PrimeStore MTM technology is designed to enable safe sample handling and testing for multiple pathogens from one sample swab
GSK and Medicago announce collaboration to develop a novel adjuvanted COVID-19 candidate vaccine
Collaboration combines innovative plant-based and adjuvant technologies to develop and produce a COVID-19 candidate vaccine
PerkinElmer collaborates with Sonora Quest Laboratories to expand COVID-19 testing in Arizona
The strategic partnership aims to catapult COVID-19 diagnostic testing capacity well ahead of the significant demand
BD launches portable, rapid point-of-care antigen test to detect SARS-CoV-2 in 15 minutes
This is the company's third diagnostic test to receive Emergency Use Authorization by U.S. FDA for detecting COVID-19
Scientists crack bacteria quantification challenge in quest for novel infection therapies
Dr. Dennis Nurjadi discusses the cell counting technology that has brought his team accuracy and reproducibility























